Celiac Disease Foundation At The New York Stock Exchange
In this special conversation from the New York Stock Exchange, Celiac Disease Foundation Chief Advancement Officer Brett Spitale and investment manager Gregg Stein discuss the growing momentum behind celiac disease…
Continue Reading